Spontaneous resolution of Epstein-Barr virus-induced haemophagocytic lymphohistiocytosis in Still's disease treated by tocilizumab: a case report.

Authors :: Ebstein, E
Ea, H-K
Source :: Scandinavian Journal of Rheumatology; Jan2018, Vol. 47 Issue 1, p84-85, 2p
Publication Year :: 2018
Abstract: The article presents a case study of Epstein-Barr virus (EBV)-induced haemophagocytic lymphohistiocytosis (HLH) in a 28-year-old man with adult-onset Still's disease (AOSD). It mentions that the condition occured after initiating a subcutaneous tocilizumab (TCZ) therapy for AOSD. It notes that management of HLH depends on serum ferritin levels, age, and the presence of organ failure.

Subjects :: EPSTEIN-Barr virus diseases
IMMUNOLOGICAL deficiency syndromes
RHEUMATOID arthritis treatment
TOCILIZUMAB
DRUG side effects
TREATMENT effectiveness
THERAPEUTIC use of monoclonal antibodies
EPSTEIN-Barr virus
HEMOPHAGOCYTIC lymphohistiocytosis
RHEUMATOID arthritis
DISEASE complications

Full Text Access

Tools